LBIO (Longevity Biomedical) Total Operating Expense: $0.00 Mil (TTM As of . 20)


What is Longevity Biomedical Total Operating Expense?

Longevity Biomedical LBIO Total Operating Expense is $0.00 Mil as of . 20.

Longevity Biomedical's Total Operating Expense for the six months ended in . 20 was $0.00 Mil. Longevity Biomedical's Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Longevity Biomedical Total Operating Expense Related Terms

Longevity Biomedical Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Total Operating Expense Chart

Longevity Biomedical Annual Data
Trend
Total Operating Expense

Longevity Biomedical Semi-Annual Data
Total Operating Expense

Longevity Biomedical Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


For stock reported annually, GuruFocus uses latest annual data as the TTM data. Total Operating Expense for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.00 Mil mean?
Longevity Biomedical (LBIO) has a Total Operating Expense of $0.00 Mil as of . 20. Total operating expense is the primary recurring expense associated with central operations. View historical data on Longevity Biomedical and its competitors.
Is Longevity Biomedical's Total Operating Expense too high?
Longevity Biomedical's current Total Operating Expense is $0.00 Mil.
How does Longevity Biomedical's Total Operating Expense compare to ?
Longevity Biomedical's Total Operating Expense of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Longevity Biomedical and its competitors. Longevity Biomedical's current Total Operating Expense is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current Total Operating Expense of $0.00 Mil. The current Total Operating Expense is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current Total Operating Expense is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.